Indian (NIFTY) Clinical Research and Equipment Industry Analysis
UpdatedMay 28, 2022
DataAggregated Company Financials
Companies13
- 7D-15.2%
- 3M-12.6%
- 1Y-14.4%
- YTD-22.4%
Over the last 7 days, the Clinical Research and Equipment industry has dropped 15%, driven by Divi's Laboratories declining 18%. In contrast, Tarsons Products has gained 6.2%. Overall the industry is down 14% in 12 months. Looking forward, earnings are forecast to grow by 7.2% annually.
Industry Valuation and Performance
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Sun, 29 May 2022 | ₹1.2t | ₹158.0b | ₹34.0b | 31.5x |
| Tue, 26 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 35.6x |
| Thu, 24 Mar 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 34.9x |
| Sat, 19 Feb 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 36.8x |
| Mon, 17 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 40.5x |
| Wed, 15 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 32.4x |
| Fri, 12 Nov 2021 | ₹1.6t | ₹134.6b | ₹23.6b | 23.9x |
| Sun, 10 Oct 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 22.9x |
| Tue, 07 Sep 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 25.3x |
| Thu, 05 Aug 2021 | ₹1.6t | ₹127.1b | ₹22.6b | 39.6x |
| Sun, 09 May 2021 | ₹1.4t | ₹121.4b | ₹21.5b | 40.3x |
| Wed, 10 Feb 2021 | ₹1.2t | ₹116.0b | ₹22.4b | 38.3x |
| Tue, 03 Nov 2020 | ₹1.1t | ₹114.7b | ₹22.2b | 28.5x |
| Fri, 07 Aug 2020 | ₹929.8b | ₹116.1b | ₹19.8b | 46x |
| Thu, 30 Apr 2020 | ₹771.1b | ₹116.7b | ₹17.2b | 28.4x |
| Sun, 02 Feb 2020 | ₹664.2b | ₹101.6b | ₹18.5b | 31.7x |
| Wed, 06 Nov 2019 | ₹657.8b | ₹104.8b | ₹20.4b | 24.6x |
| Sat, 10 Aug 2019 | ₹620.8b | ₹101.2b | ₹19.9b | 31.9x |
Median PE Ratio
31.2x
Current Industry PE
- Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 33.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 22% per year over the last three years.
- Revenues for these companies have grown 18% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Clinical Research and Equipment compare with similar industries?
| IN Market | -0.87% | |
| Healthcare | -1.99% | |
| Life Sciences | -15.25% | |
| Clinical Research and Equipment | -15.25% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| TARSONS Tarsons Products | ₹690.10 | 6.2% +₹2.1b | n/a | PS36.5x | |
| 538837 Jeevan Scientific Technology | ₹83.05 | 3.7% +₹45.1m | -10.9% | PS8.4x | |
| 533543 Brooks Laboratories | ₹83.60 | 2.2% +₹44.5m | -18.8% | PS2.7x | |
| 539267 Dr Habeebullah Life Sciences | ₹26.00 | 2.4% +₹8.9m | -20.1% | PB3.5x |